NMD Pharma Raises €35 Million in a new Financing
NMD Pharma Raises €35 Million in a new Financing – New investor Jeito Capital joins…
News
Aleafia Health Reports Q4 2021 Financial Results with $11.5 Million Branded Cannabis Gross Revenue, representing a 103% Increase from 2020
Transforming business towards a branded cannabis provider, with branded revenue representing 80% of total net…
CoinDCX Enhances Anti-Money Laundering Protection, Announces Partnership With Cryto-native Trade Surveillance And Market Integrity Leader Solidus Labs
An industry-first in India, CoinDCX leverages Solidus Labs’ machine-learning detection models to strengthen trust and…
InMed Pharmaceuticals Reports Second Quarter Fiscal 2022 Financial Results and Provides Business Update
Completed acquisition of BayMedica, a rare cannabinoid manufacturing and commercialization company in the health and…
ECMOHO Increases Digital Marketing Efforts To Drive Growth
SHANGHAI, China, Feb. 15, 2022 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the…
The Essential Coin Continues to Make Inroads in Their Mission to Be Next Big Cryptocurrency
Dallas, Texas–(Newsfile Corp. – February 14, 2022) – The Essential Coin is proud to announce…
Arvinas Announces New Data from Completed Phase 1 Dose Escalation and Ongoing Phase 2 ARDENT Expansion Cohort with Novel PROTAC® Degrader Bavdegalutamide (ARV-110) to be Presented at 2022 ASCO GU Meeting
– Bavdegalutamide demonstrated a 46% PSA50 rate in patients with metastatic castration-resistant prostate cancer (mCRPC)…
AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma
Five year follow-up data show FOTIVDA® (tivozanib) patients up to 5X more likely to experience…
Vimeo January 2022 Monthly Metrics Available on Company’s IR Site
NEW YORK, Feb. 14, 2022 (GLOBE NEWSWIRE) — Vimeo posted monthly metrics for January 2022…
Turnium Technology Group Inc. Lights Up Central and South America
Turnium’s new partner delivers more reliable connectivity to Central and South American service providers, enterprise,…
D.A. Davidson & Co. Acts as Exclusive Financial Advisor to Protecht Group in Its Significant Growth Investment From Arrowroot Capital
PORTLAND, Ore.–(BUSINESS WIRE)–#DADavidsonIB—D.A. Davidson & Co. announced today that it has served as exclusive financial…
Otter Tail Corporation Announces Fourth Quarter Earnings, Increases Quarterly Dividend 5.8% and Announces 2022 Earnings Guidance of $3.78 to $4.08 per share
FERGUS FALLS, Minn.–(BUSINESS WIRE)–Otter Tail Corporation (Nasdaq: OTTR) today announced financial results for the quarter…
Bain Capital Specialty Finance, Inc. Announces Formation of Bain Capital Senior Loan Program, LLC
BOSTON–(BUSINESS WIRE)–Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”) today announced the formation of…
Strategy Analytics: Green Mobile Operators Need Holistic Approach to Achieve Net Zero Target
Improving energy efficiency is key for operators’ sustainable growth BOSTON–(BUSINESS WIRE)–With more and more countries,…
KBRA Assigns Preliminary Ratings to ABPCI Direct Lending Fund ABS II LLC
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to four classes of notes issued by ABPCI Direct…
VICI Properties Inc. Announces Extension of Exchange Offers
NEW YORK–(BUSINESS WIRE)–VICI Properties Inc. (NYSE: VICI) (the “Company”) announced today that its wholly owned…
Nerdy to Announce Fourth Quarter and Full Year 2021 Results on Feb. 28, 2022
ST. LOUIS–(BUSINESS WIRE)–Nerdy Inc. (NYSE: NRDY), a leading platform for delivering live online learning, today…
Primerica Reports Fourth Quarter 2021 Results
Investment and Savings Products sales increased 46% with sales exceeding $3 billion for the quarter…
Amendment of proposals put forward at the Extraordinary General Meeting
Orphazyme A/SCompany announcementNo. 04/2022 www.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 14, 2022 – Orphazyme A/S (ORPHA.CO;…
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
BALA CYNWYD, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR),…